Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 13, 2024Cell Death and DiseaseOpen Access

STING agonist diABZI enhances the cytotoxicity of T cell towards cancer cells

View Full Paper
Ask AI
Bookmark
Share

Authors

LWLing WangBeijing University of Chinese MedicineZLZhaoduan LiangGuangzhou Regenerative Medicine and Health Guangdong LaboratoryYGYunzhuo GuoUniversity of Science and Technology of China

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2024) studied this question.

synapsesocial.com/papers/68e6f4b7b6db64358766f1bfhttps://doi.org/10.1038/s41419-024-06638-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Interferon‐α promotes MHC I antigen presentation of islet β cells through STAT1‐IRF7 pathway in type 1 diabetes2022 · 31 citations
  2. 2Distinct Requirements for IFNs and STAT1 in NK Cell Function2000 · 218 citations
  3. 3CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review2018 · 1,784 citations
  4. 4Dependence of T Cell Antigen Recognition on T Cell Receptor-Peptide MHC Confinement Time2010 · 269 citations
  5. 5STING Agonists as Cancer Therapeutics2021 · 405 citations